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Abstract
Triggering receptors expressed on myeloid cells (TREM) form a multigene family of immu-
noregulatory Ig-like receptors and play important roles in the regulation of innate and adap-
tive immunity. In chickens, three members of the TREM family have been identified on
chromosome 26. One of them is TREM-B1 which possesses two V-set Ig-domains, an
uncharged transmembrane region and a long cytoplasmic tail with one ITSM and two ITIMs
indicating an inhibitory function. We generated specific monoclonal antibodies by immuniz-
ing a Balb/c mouse with a TREM-B1-FLAG transfected BWZ.36 cell line and tested the
hybridoma supernatants on TREM-B1-FLAG transfected 2D8 cells. We obtained two differ-
ent antibodies specific for TREM-B1, mab 7E8 (mouse IgG1) and mab 1E9 (mouse IgG2a)
which were used for cell surface staining. Single and double staining of different tissues,
including whole blood preparations, revealed expression on thrombocytes. Next we investi-
gated the biochemical properties of TREM-B1 by using the specific mab 1E9 for immuno-
precipitation of either lysates of surface biotinylated peripheral blood cells or stably
transfected 2D8 cells. Staining with streptavidin coupled horse radish peroxidase revealed
a glycosylated monomeric protein of about 50 kDa. Furthermore we used the stably trans-
fected 2D8 cell line for analyzing the cytoplasmic tyrosine based signaling motifs. After per-
vanadate treatment, we detected phosphorylation of the tyrosine residues and subsequent
recruitment of the tyrosine specific protein phosphatase SHP-2, indicating an inhibitory
potential for TREM-B1. We also showed the inhibitory effect of TREM-B1 in chicken throm-
bocytes using a CD107 degranulation assay. Crosslinking of TREM-B1 on activated pri-
mary thrombocytes resulted in decreased CD107 surface expression of about 50–70%.
Introduction
A balanced immune reaction is important to avoid either insufficient or exaggerated immune
responses. Therefore the cells interact via a network of either activating or inhibitory signals,
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which fine-tune the outcome of the immune response. Many of these cell-cell interactions are
still poorly understood, but a group of so called immunoregulatory receptors are very likely to
be involved in this process [1–3]. They are cell surface receptors with either activating or inhib-
itory signaling potential which are biochemically divided in two different groups and belong to
either type II transmembrane C-type lectins [4] or type I transmembrane Ig-superfamily mem-
bers [5]. Activating receptors have a short cytoplasmic tail without any signaling capabilities,
but display a positively charged amino acid in the transmembrane region, which can be either
arginine or lysine. This is associated with the negatively charged residue of an ITAM contain-
ing adaptor molecule, which is DAP12 or common γ chain. An ITAM is a so-called immunore-
ceptor-tyrosine based activating motif, which is phosphorylated after receptor crosslinking and
triggers intracytoplasmic activation cascades [6, 7]. The inhibitory receptors have an uncharged
transmembrane region, but a long cytoplasmic tail with a different number of immunorecep-
tor-tyrosine-based-inhibitory motifs (ITIMs). Interaction with the specific ligand leads to
phosphorylation of these tyrosines and subsequent recruitment of tyrosine specific protein
phosphatases like src-homology phosphatase-1 (SHP-1), SHP-2 or Src homology 2-containing
inositol 5'-phosphatase (SHIP) which are dephosphorylating downstream target molecules [8,
9].
Immunoregulatory Ig-like receptors are also present in chickens. One family are the chicken
Ig-like receptors (CHIR), which were discovered in 2000 [10] and characterized in recent years
by us and other groups [11–18].
The availability of the first assembly of the chicken genome in 2004 [19] offered the oppor-
tunity to further investigate additional immunoregulatory Ig-like receptor families by extended
homology searches. By this method, we characterized the TREM (triggering receptors
expressed on myeloid cells), SIRP (signal-regulatory proteins), CD200R (CD200 receptor fam-
ily) and CD300L (CD300 antigen like family members) [20–23].
The chicken TREM family is located on chicken chromosome 26. It comprehends of one
potentially activating receptor TREM-A1 and two potentially inhibitory receptors TREM-B1
and TREM-B2 [20]. TREM-A1 consists of a single V-set Ig-domain, a charged transmembrane
region and a short cytoplasmic tail. TREM-B1 and TREM-B2 both display two extracytoplas-
mic V-set Ig-domains, an uncharged transmembrane region and a long cytoplasmic tail. The
cytoplasmic tail of TREM-B1 encodes for one ITSM (immunoreceptor-tyrosine switch motif)
and two ITIMs, whereas TREM-B2 only has two ITIMs. Interestingly, for TREM-B2 we cloned
two splice variants either with one or two extracellular Ig-domains followed by the transmem-
brane and cytoplasmic region [20]. At that time the chromosomal region encoding the TREM
family members was still unassembled in the chicken genome. Meanwhile we analyzed a
completely sequenced BAC clone which included all TREMmembers and the unrelated flank-
ing genes, which we used, apart from other characteristics, for assigning synteny to corre-
sponding mammalian receptors. This is gallus gallus BAC clone CH261-94J19 (Acc. No.:
AC161468). In addition to our initial characterization, we found that the TREM-B2 gene dis-
played four extracytoplasmic V-set Ig-domains, which probably arose by duplication of a two
domain receptor, because they were identical to each other by 97.4% on nucleotide level. We
verified this third splice variant for TREM-B2 by cDNA cloning (Viertlboeck et al.,
unpublished).
Recently, we examined the expression pattern of the activating TREM-A1 by generating a
specific monoclonal antibody (mab) [22]. We showed high TREM-A1 expression on blood
and bone marrow monocytes, macrophages, heterophils (which are the avian homologues to
neutrophils) and on a newly discovered population of blood NK cells [24]. Furthermore we
detected lower TREM-A1 expression on thrombocytes and B and T cell subsets. Additionally,
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we found TREM-A1 expression also in chicken brain cells, including microglial cells, neurons,
astrocytes and oligodendrocytes.
In this report, we show detailed expression analysis of TREM-B1 employing two newly
established mab. We found TREM-B1 to be expressed on chicken thrombocytes. Furthermore
we used the specific mab to immunoprecipitate TREM-B1 protein from cell lysates of either
PBMC or stably transfected 2D8 cells and we used this cell line to show that the tyrosine resi-
dues in the cytoplasmic region can be phosphorylated and recruit SHP-2. Moreover, we dem-
onstrated that crosslinking of TREM-B1 resulted in a reduced surface expression of the
degranulation marker CD107 on activated thrombocytes.
Materials and Methods
Ethics statement
All of the experimental procedures were in accordance with institutional, state and federal
guidelines on animal welfare. The animal experiments were approved by the committee for the
Care and Use of Laboratory Animals of the Government of Upper Bavaria, Germany (permit
number: 55.2-1-54-2531.6–12.09) and all efforts were made to minimize animal suffering dur-
ing experiments.
Animals
Chicken line M11 was kindly provided by S. Weigend (Federal Research Institute for Animal
Health, Mariensee, Germany). Fertilized Eggs were incubated and hatched at the Institute for
Animal Physiology, University of Munich. The animals were housed under conventional con-
ditions and experiments were performed at the age of 3 to 10 weeks. Balb/c mice were obtained
from Charles River Wiga GmbH (Sulzfeld, Germany) and raised at the institute.
Cell preparation
Leukocytes of chicken bursa, caecal tonsils, spleen and thymus were obtained by passing the
organs through a stainless steel mesh and subsequent density centrifugation of the single cell
suspension on Biocoll Separating Solution (Biochrom AG, Berlin, Germany). Heparinized
whole blood was used to isolate either peripheral blood lymphocytes (PBL) by slow speed cen-
trifugation [24] or peripheral blood mononuclear cells (PBMC) by density centrifugation [25].
Preparation of monocyte-derived macrophages was performed by in vitro culture of PBMC in
RPMI 1640 (Biochrom AG, Berlin, Germany) supplemented with 8% FCS (Biochrom AG, Ber-
lin, Germany) and 2% chicken serum (Life Technologies, Carlsbad, CA, USA) for 2 days (40°C,
5% CO2) [26]. For whole blood analysis by flow cytometry, EDTA-treated blood was diluted in
PBS supplemented with 1% BSA and 0.01% NaN3.
Cloning procedures
The expression constructs established in this study were generated by using cDNA templates
obtained in a previous study [20] and specific oligonucleotides are summarized in Table 1. For
the TREM-B1-FLAG construct, primers 1791 and 1792 were used on a TREM-B1 cDNA (Acc.
No.: AM076722). The resulting PCR fragments were gel extracted and coupled to a modified
pcDNA3.1/V5-His TOPO Vector (Life Technologies, Carlsbad, CA, USA) containing an N-
terminal FLAG epitope tag by using the Gibson Assembly™Master Mix (New England BioLabs
Inc., Massachusetts, USA). The TREM-B1-FLAG-muCD3z expression construct was generated
as the TREM-A1-FLAG-muCD3z construct described previously [22]. Briefly, the respective
extracellular domains were amplified by PCR with primers 1148 and 1149, gel purified and
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EcoRI digested followed by ligation into a modified pcDNA3.1/V5-His TOPO Vector (Life
Technologies, Carlsbad, CA, USA) resulting in an N-terminally FLAG-tagged extracellular
region of TREM-B1 fused to the transmembrane region of chicken CD8α and the cytoplasmic
domain of murine CD3z. For generation of the TREM-B2-FLAG-muCD3z construct, the same
cloning vector was used, but ligation of the two extracellular Ig-domains, which were amplified
by primers 1748 and 1748 on TREM-B2 cDNA (Acc. No.: AM076723), was performed with
the Gibson Assembly™Master Mix. Accuracy of the constructs was verified by gene sequencing
(GATC, Konstanz, Germany).
Cell lines, transfection and expression
The mouse thymoma cell line BWZ.36 [27] was stably transfected by electroporation [28]
using 25 μg of TREM-B1-FLAG-muCD3z (3 x 106 cells, 200 V with 950 μF capacitance).
Transfected cells were seeded into a 96-well flat bottom plate and selected in RPMI 1640 (Bio-
chrom AG, Berlin, Germany) supplemented with 10% FCS and 0.8 mg/ml G418 (Biochrom
AG, Berlin, Germany) for 10 days (37°C, 5% CO2). The chicken B cell line 2D8 [29] was stably
transfected with a full-length TREM-B1-FLAG construct using Metafectene Pro (Biontex, Pla-
negg, Germany). After incubation of 24 h (40°C, 5% CO2) the transfected cells were plated in a
96-well flat bottom plate and cultured in RPMI medium containing 10% FCS and 0,8 mg/ml
G418 (Biochrom AG, Berlin, Germany) for 2 weeks. Single clones were screened for surface
expression by anti-FLAG staining and subsequent flow cytometry (FACSCanto II, BD, Heidel-
berg, Germany). A BWZ.36 cell line stably expressing TREM-A1-FLAG-muCD3z was estab-
lished in a previous study [22]. In addition, human embryonic kidney HEK 293 T cells were
transiently transfected with a TREM-B2-FLAG-muCD3z construct using the Metafectene lipo-
somal transfection reagent (Biotex, Planegg, Germany) and used for further analysis after 24 h.
Real-time RT-PCR
RNA preparation and real-time RT-PCR was performed as described previously [22]. Total
RNA of bursa, thymus, caecal tonsils, liver, spleen, bone marrow and PBMC was extracted
from 100 mg tissue or 1 x 107 cells by using Trizol (Life Technologies, Carlsbad, CA, USA).
The RNA quality was determined with the 2100 Bioanalyzer (Agilent Technologies, Wald-
bronn, Germany) and RNA with an integrity number abover 7.5 was used for cDNA synthesis
with the QuantiTect Reverse Transkription Kit (Qiagen, Hilden, Germany). PCR was per-
formed with the PowerSYBR1 Green RT-PCR Reagents Kit (Applied Biosystems, Darmstadt,
Germany) using the 7300 Real-Time PCR System (Applied Biosystems, Darmstadt, Germany)
with following parameters: 95°C for 10 min, then 40 cycles of 95°C for 15 s, and 59°C for 1 min
Table 1. Oligonucleotides used for cloning.
Specificity Number Sequenceb
TREM-B1-FLAG construct 1791sa GGACGATGACGATAAGGCAGGAGAGGACACGCAAG
TREM-B1-FLAG construct 1792as AGAATTGCCCTTGAACTTCTATAGGGTTGTGTCCT
TREM-B1-FLAG –muCD3ζ 1148s ATGAATTCGCAGGAGAGGACACG
TREM-B1-FLAG –muCD3ζ 1149as ATGAATTCAGCATAGGGGGTCCT
TREM-B2-FLAG –muCD3ζ 1748s GGACGATGACGATAAGGGTCTCCCAGCCCAAACAG
TREM-B2-FLAG –muCD3ζ 1749as TGGATATCTGCAGAATTTTGTGATGGTGTTCCGTG
aOrientation indicated as s sense and as antisense
b Restiction site underlined
doi:10.1371/journal.pone.0151513.t001
Chicken TREM-B1
PLOSONE | DOI:10.1371/journal.pone.0151513 March 11, 2016 4 / 19
with subsequent analysis by a melting curve. The cDNA samples were analyzed in triplicates
with oligonucleotides specific for TREM-B1 and 18S rRNA (Table 2) obtaining the cycle
thresholds (Ct) for each tissue. The relative amounts of gene-of-interest mRNA were calculated
by means of the ΔΔCt method as described before [21].
Generation of a specific monoclonal antibody
Two monoclonal antibodies with different isotypes were generated as described previously
[11]. Briefly, a Balb/c mouse was repeatedly immunized with the TREM-B1-FLAG-muCD3z
transfected BWZ.36 cells. Hybridoma supernatants were screened by flow cytometry on
TREM-B1-FLAG transfected 2D8 cells thereby excluding nonspecific mab binding to irrele-
vant BWZ.36 proteins. For additional verification of the mab specificities, the supernatants
were also tested on the TREM-B1-FLAG-muCD3z transfected BWZ.36 cells and on both
untransfected BWZ.36 and 2D8 cells. Cross-reaction with other structurally similar TREM
members was examined by staining TREM-A1-FLAG-muCD3z transfected BWZ.36 and
TREM-B2-FLAG-muCD3z transfected 293T cells. For our further analysis of TREM-B1, we
selected the mab 1E9 (mouse IgG2a) and 7E8 (mouse IgG1). For whole blood staining, the
mab 1E9 was affinity purified by protein G coupled agarose, subsequently concentrated using
centrifugal filters (Merck Millipore, Darmstadt, Germany) and conjugated to the Alexa Fluor
647 dye (Life Technologies GmbH-Carlsbad, CA, USA) according to the manufacturer´s
protocol.
Antibodies and immunofluorescence analysis
Single-cell staining was performed with either the 1E9 or the 7E8 mab followed by a goat-anti-
mouse IgG2a- or IgG1-PE conjugate (SBA, Birmingham, AL, USA). For double staining of leu-
kocytes, cells were first incubated with a mixture of primary mab. Depending on the isotype of
the other mab in the mixture either the anti-TREM-B1 mab 1E9 (IgG2a) or 7E8 (IgG1) was
used. Subsequently, cells were incubated with a combination of goat-anti-mouse IgG2a-PE and
goat-anti-mouse IgG1-FITC (SBA, Birmingham, AL, USA) when the 1E9 mab was used or a
mixture of goat-anti-mouse IgG2a-FITC and goat-anti-mouse IgG-1-PE when 7E8 was used
for staining. Following mab were used for further characterization of TREM-B1 expressing
cells: 8G8 (mouse IgG2a) specific for CLEC-2, which is expressed on thrombocytes [30], K1
(mouse IgG2a) recognizing an unidentified antigen expressed on thrombocytes and macro-
phages [31], AV20 (mouse IgG1) specific for Bu-1 present on B cells [32], CT3 (mouse IgG1)
specific for CD3 on T cells [33], KUL01 (mouse IgG1) specific for monocytes and macrophages
[34], 8F2 putatively recognizing a CD11c homologue expressed on chicken thrombocytes, T
cells, NK cells, monocytes, heterophils and eosinophils [24] and 8D12 specific for a chicken
FcY receptor (CHIR-AB1) expressed on B cells, monocytes and macrophages, NK cells and




18S rRNA 870s CATGTCTAAGTACACACGGGCGGTA
18S rRNA 871as GGCGCTCGTCGGCATGTATTA
aOrientation indicated as s sense and as antisense
doi:10.1371/journal.pone.0151513.t002
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heterophils [13, 22]. For each staining, appropriate isotype-matched controls were used. Dead
cells were identified by staining with 7-AAD (7-aminoactinomycin D, Sigma-Aldrich,
St. Louis, MO, USA) and the vital leukocyte population was analyzed by flow cytometry
(FACSCanto II, BD, Heidelberg, Germany) using the BD FACS DIVA 6.1.3 and FlowJo Soft-
ware (Tree Star inc., Ashland, OR, USA). Whole blood staining was performed with the Alexa
Fluor 647-conjugated 1E9 mab combined with a phycoerythrin-conjugated K1 mab [31] and
analyzed by flow cytometry as described previously [35].
Biotinylation and pervanadate treatment of cells
Biotinylation and pervanadate treatment of cells were performed as described previously [11].
For biotinylation, 5 x 107 of TREM-B1 transfected 2D8 cells or 1 x 108 prepared PBMC were
washed in PBS containing 1 mMMgCl2 and 0.1 mM CaCl2. After the cells were incubated in
PBS with 0.5 mg/ml sulfo-NHS-biotin (Life Technologies, Carlsbad, CA, USA) for 40 min at
4°C under constant rotation, the cells were washed once in RPMI 1640 followed by two washes
in PBS with MgCl2 and CaCl2. Efficiency of biotinylation was checked by flow cytometry using
phycoerythrin-conjugated streptavidin (SBA, Birmingham, AL, USA). Pervandate treatment
was conducted with 5 x 107 cells in 5 ml of warm (37°C) medium. After stimulation for 0, 5
and 15 min with 0.1 mM Na3VO4 with 0.05% H2O2 at 37°C, cells were immediately pelleted by
centrifugation at 4°C and washed twice in cold (4°C) PBS containing 0.4 mM EDTA and 0.4
mMNa3VO. Subsequently, cells were lysed for 45 min on ice using a lysis buffer consisting of
150 mMNaCl, 40 mM TRIS-Cl pH 7.4 and 1 mM EDTA supplemented with 1% TritonX-100,
the protease inhibitor cOmplete (Roche, Basel, Switzerland) and in case of pervandate stimula-
tion phosphatase inhibitors (10 mM NaF, 2 mM EDTA, 1 mMNa3VO4). Supernatant was sep-
arated from nuclear and insoluble components by centrifugation for 30 min at 4°C and 16,000
x g and subsequently used for immunoprecipitation.
Immunoprecipitation, deglycosylation and immunoblotting
Immunoprecipitation was performed with 50 μl of either anti-Flag M2 Agarose Affinity Gel
(Sigma-Aldrich, St. Louis, MO, USA) or protein G-coupled agarose (Merck Millipore, Darm-
stadt, Germany) loaded for 4 h with 1.5 μg of the purified 1E9 mab and washed once with lysis
buffer before use. Lysates were added to the agarose-beads and incubated over night at 4°C
under constant rotation. The beads were washed three times in lysis buffer by centrifugation
before immunoprecipitates were eluted by boiling the beads in 100 μl of SDS sample buffer.
For deglycosylation, immunoprecipitates were dissolved in a glycoprotein denaturing buffer
followed by incubation in a buffer containing peptide N glycosidase F (PNGase, New England
BioLabs, Ipswich, MA, USA) according to the manufacturer´s protocol. Precipitated proteins
were separated on 12% SDS-PAGE under nonreducing and reducing conditions followed by
transmission on a 0.45 μm nitrocellulose membrane (Amersham Hybond-ECL, GE Healthcare,
Solingen, Germany) by semidry electroblotting. The blots were blocked in 5% nonfat dry milk
in PBS supplemented with 0.05% Tween and subsequently incubated with a streptavidin-HRP
(horseradish peroxidase) conjugate (1:10000, SBA, Birmingham, AL, USA), an anti-FLAG--
POD (peroxidase) conjugate (1:20000, Sigma-Aldrich, St. Louis, MO, USA) for loading control
or a HRP conjugated anti-phosphotyrosine antibody (P-Tyr (Py20) HRP, 1:200, Santa Cruz
Biotechnology, Dallas, TX, USA) for phosphotyrosine detection. Phosphatase detection was
conducted by using a rabbit anti-human-SHP-2 antiserum (SH-PTP 2 (C-18), 1:200, Santa
Cruz Biotechnology, Dallas, TX, USA) followed by goat anti-rabbit IgG(H+L)-HRP (1:10000,
Jackson ImmunoResearch Inc., West Grove, PA, USA). Immunoblotted proteins were visual-
ized using a luminol-based chemiluminescent substrate. This consists of three components:
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ECL-A solution containing 0.1 M TRIS-HCl ad 100 ml aqua dest. pH 8.6 supplemented with
25 mg Luminol (Sigma-Aldrich, St. Louis, MO, USA), ECL-B solution comprised of 0.110 g
parahydroxy coumarin acid (Sigma-Aldrich, St. Louis, MO, USA) solved in 100 ml DMSO and
ECL-C solution which is H2O2 30% (v/v).
CD107 degranulation assay
To investigate the inhibitory potential of TREM-B1, the CD107 degranulation assay was per-
formed [36]. 5 x 105 PBMC were incubated simultaneously with the CLEC-2 specific mab 8G8
(mouse IgG2a) and the TREM-B1 specific mab 1E9 (mouse IgG2a), a goat-anti-mouse IgG2a-
FITC conjugate (SBA, Birmingham, AL, USA) for co-crosslinking and the 5G10 mab detecting
chicken CD107 (mouse IgG1, Developmental Studies Hybridoma Bank, University of Iowa) in
the presence of the protein transport inhibitor GolgiStop™ (BD, Heidelberg, Germany). An
appropriate isotype-matched control was performed identically, but in the presence of an irrel-
evant mouse IgG2a antibody instead of the 1E9 mab. Following incubation for 30 min (40°C,
5% CO2), the cells were stained with an anti-IgG1-PE antibody (SBA, Birmingham, AL, USA).
Dead cells were discriminated using 7-AAD (7-aminoactinomycin D, Sigma-Aldrich, St. Louis,
MO, USA) and living cells were analyzed by flow cytometry. Additional controls without cross-
linking were incubated in the absence of 8G8 and 1E9 or the irrelevant antibody and stained
with the respective antibodies at the end of the experiment. To determine the percentage of
TREM-B1 induced inhibition, the fraction of CD107 positive cells out of the whole thrombo-
cyte population was calculated and referred to the isotype-matched control, which were set to
100% degranulation. Statistical analysis was perfomed by using Graph Pad Prism software ver-
sion 5.
Results
The mab 1E9 and 7E8 are specific for TREM-B1 and do not cross-react
with other TREMmembers
In order to generate a monoclonal antibody against the extracellular domain of TREM-B1, two
different cell lines were established. Immunization was conducted with a TREM-B1-FLAG-
muCD3z transfected BWZ.36 cell line followed by screening of the hybridoma supernatants on
chicken 2D8 cells stably expressing TREM-B1-FLAG (Fig 1). By this strategy, nonspecific mab
detecting irrelevant BWZ.36 proteins were excluded. Two specific mab with different isotypes
were selected, designated 1E9 (mouse IgG2a) and 7E8 (mouse IgG1). For validation of specific-
ity, the obtained mab 1E9 and 7E8 were also tested on untransfected 2D8 and BWZ.36 cells as
well as on TREM-B1-FLAG-muCD3z transfected BWZ.36 cell line (Fig 1). Both antibodies
bound to nearly all transfected cells, whereas unspecific binding to the untransfected control
cells could be excluded.
To test whether the mab could cross-react with other members of the chicken TREM family,
1E9 and 7E8 supernatants were also tested on TREM-A1-FLAG-muCD3z and TREM-B2--
FLAG-muCD3z transfected cells. Both mab reacted well with TREM-B1 (Fig 2A), but did not
cross-react with the other TREM family members (Fig 2B and 2C). Surface expression of the
respective proteins was validated by anti-FLAG staining.
TREM-B1 is expressed on thrombocytes
To investigate TREM-B1 protein expression, cell surface staining with the 7E8 mab on leuko-
cyte preparations obtained from different tissues was conducted. Dead cells were stained with
7-AAD and excluded from the analysis. Lymphocytes from bursa, thymus and caecal tonsils
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Fig 1. 1E9 and 7E8 are specifically recognizing TREM-B1 protein. TREM-B1-FLAG transfected 2D8 and untransfected 2D8 cells were incubated with
either the 1E9 or the 7E8 mab (filled histograms) and analyzed by flow cytometry (upper panels). TREM-B1-FLAG-muCD3ζ transfected BWZ.36 and
untransfected BWZ.36 cells were tested in the same way (lower panels). Isotype-matched controls are shown as open histograms and percentages of
positive cells are indicated as numbers.
doi:10.1371/journal.pone.0151513.g001
Fig 2. Themab 1E9 and 7E8 do not cross-react with other TREM family members. BWZ.36 cells stably
expressing TREM-B1-FLAG-muCD3ζ (A) or TREM-A1-FLAG-muCD3ζ (B) and transiently transfected HEK-
293T cells expressing TREM-B2-FLAG-muCD3ζ (C) were stained with an isotype-matched negative control
(left panels), an anti-FLAGmab as expression control (middle panels, left) and the mab 1E9 (middle panels,
right) and 7E8 (right panels). Numbers indicate the percentage of positive cells.
doi:10.1371/journal.pone.0151513.g002
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showed no reactivity (Fig 3, upper panels). Only slight expression was found on cells from
spleen and bone marrow and the highest expression was found on PBMC (Fig 3, lower panels),
which is in accordance with real-time RT-PCR analysis (S1 Fig). Based on these results, double
immunofluorescence staining on PBMC with antibodies specific for different cell populations
was performed. Depending on the isotype of these antibodies, either the 1E9 or the 7E8 mab
was applied. Living cells were identified by 7-AAD staining and either gated on lymphocytes/
thrombocytes (R1), monocytes/NK cells (R2) or heterophils (R3) in FSC/SSC (Fig 4A). PBMC
preparations of ten different animals were analyzed. Using the thrombocyte markers K1 or
8G8, all thrombocytes were found to be positive for TREM-B1 (Fig 4A, R1 gate, lower panels).
The number of thrombocytes in the different preparations varied from 33.7% to 77.6%. In con-
trast, staining of lymphocytes (Fig 4A, R1 gate, upper panels), monocytes and NK cells (Fig 4A,
R2 gate) and heterophils (Fig 4A, R3 gate) yielded no double positive population. Further anal-
yses with the thrombocyte marker 23C6, the MHCII specific mab 2G11 and the 8C7 mab rec-
ognizing SLAMF4 (CD244) on thrombocytes, monocytes, NK cells and subsets of T cells and B
cells, confirmed TREM-B1 expression is restricted to thrombocytes (data not shown).
To investigate the slight TREM-B1 expression on cells from spleen and bone marrow, these
cells were also examined by double staining with the same antibody panel tested on PBMC
(except 2G11 and 8C7). In compliance with PBMC staining, again thrombocytes were identi-
fied to be the only TREM-B1 expressing population (data not shown).
In addition, monocyte-derived macrophages were analyzed for TREM-B1 expression, but
showed no reactivity (Fig 4B). In accordance with this, the chicken macrophage cell lines
HD11 and BM-2 were also negative for TREM-B1 (data not shown).
Thrombocytes can be easily activated. In order to check the impact of cell density centrifu-
gation on thrombocyte protein expression level of TREM-B1, whole blood was analyzed using
the Alexa Fluor 647-conjugated 1E9 mab combined with a phycoerythrin-conjugated K1
Fig 3. TREM-B1 is predominantly expressed on PBMC. Leukocytes obtained from bursa, thymus, caecal
tonsils, spleen, bone marrow and blood (PBMC) were incubated with the 7E8 mab and analyzed by flow
cytometry. The markers were set according to an isotype-matched negative control and the percentage of
positive cells is indicated as a number. One of three representative experiments is shown.
doi:10.1371/journal.pone.0151513.g003
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antibody and compared with thrombocytes prepared by density centrifugation. The entire leu-
kocyte population of both PBMC and whole blood was gated by their light scatter characteris-
tics in FSC/SSC (Fig 5, upper panels) and analyzed by flow cytometry. However, there was no
difference in TREM-B1 expression level (Fig 5, lower panels).
TREM-B1 is expressed as a glycosylated monomer
For biochemical analyses of TREM-B1, 2D8 cells expressing TREM-B1-FLAG were surface
biotinylated, immunoprecipitated by the anti-TREM-B1 mab 1E9 and an irrelevant isotype
control and subsequently analyzed by western blot. Under non-reducing conditions, a protein
Fig 4. TREM-B1 is expressed on thrombocytes. (A) Viable PBMCwere discriminated by 7-AAD staining
and gated on lymphocytes/thrombocytes (R1), monocytes/NK cells (R2) or heterophils (R3) in FSC/SSC.
Cells were double immunofluorescence stained with either the 1E9 (upper panel) or the 7E8 (lower panel)
mab in combination with several cell surface markers as indicated. Numbers indicate the percentage of cells
in the respective quadrants. Isotype-matched controls were included in each experiment. One of ten
representative experiments is shown. (B) Macrophages were single stained with the TREM-B1 specific mab
7E9 and the macrophage/monocyte specific marker KUL01 (filled histograms). Isotype-matched controls are
shown as open histograms and percentages of positive cells are indicated as numbers.
doi:10.1371/journal.pone.0151513.g004
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band of approximately 50 kDa was detected by a streptavidin-HRP conjugate (Fig 6A). Reduc-
tion of the protein yielded a single band on the same level and the addition of PNGase F for
deglycosylation resulted in a molecule band with a reduced MR of about 45 kDa, which is in
accordance with the theoretical MR of 46 kDa (Fig 6A). Therefore, TREM-B1 seems to be
expressed as a glycosylated monomer. Immunoprecipitates of the isotype control showed no
detectable protein (data not shown).
We performed similar experiments on primary PBMC and detected the same protein bands
for native TREM-B1 (Fig 6B).
TREM-B1 recruits SHP-2 upon phosphorylation
TREM-B1 contains three cytoplasmic signaling motifs, one ITSM and two ITIMs. Following
phosphorylation, downstream signaling of the receptor might include protein phosphatases.
Therefore, 2D8 cells expressing TREM-B1-FLAG were treated with pervanadate for 0, 5 and 15
minutes, respectively, and immunoprecipitated using anti-FLAG beads. The immunoblots
Fig 5. Cell preparation has no impact on the expression level of TREM-B1. PBMC obtained by density
centrifugation and whole blood were double stained with the mab 1E9 and K1 (specific for monocytes and
thrombocytes), gated on the entire leukocyte population by FSC/SSC and analyzed by flow cytometry.
Numbers indicate the percentage of cells in the respective quadrants. The marker quadrants were set
according to the unstained cells.
doi:10.1371/journal.pone.0151513.g005
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were probed with a monoclonal antibody detecting phosphotyrosine and an antiserum directed
against SHP-2. Cells treated for 0 minutes showed a weak basal level of phosphorylated tyro-
sine residues as well as weak association with SHP-2 which increased after pervanadate treat-
ment (Fig 7). Equal protein loading was proven by using an anti-FLAG-HRP conjugate for
detecting TREM-B1 with an apparent mass of 50 kDa (Fig 7).
Fig 6. TREM-B1 is expressed as a glycosylated monomer. 2D8 cells stably transfected with a
TREM-B1-FLAG construct (A) and PBMC (B) were surface biotinylated, lysed and immunoprecipitated with
the 1E9 mab. Deglycosylation was performed with PNGaseF (+) and probes were analyzed under
nonreducing (NR) and reducing (R) conditions. Following PAGE, size-fractioned proteins were blotted and
detected with a streptavidin-HRP conjugate.
doi:10.1371/journal.pone.0151513.g006
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TREM-B1 crosslinking reduces CLEC-2 induced thrombocyte
degranulation
Further examination of the inhibitory properties of TREM-B1 was performed by using the
CD107 degranulation assay. Chicken thrombocytes can be activated by CLEC-2 crosslinking,
resulting in degranulation with cell surface expression of the lysosomal protein CD107 [30].
PBMC were co-incubated with the thrombocyte specific mab 8G8 and 1E9 in the presence of a
crosslinking secondary mab and degranulation was monitored by using an antibody specific
for CD107. Dead cells were stained with 7-AAD and excluded from the analysis. 30 minutes
after co-crosslinking, CD107 expression on the entire thrombocyte population was decreased
compared to the isotype-matched control (Fig 8A, right panels). Controls without crosslinking
did only show a slight CD107 expression (Fig 8A, left panels). In five animals, the reduction
ranged from 43.7% to 61.3% (Fig 8B). For example, in Fig 8A degranulation was reduced by
61.1%.
Discussion
Members of the TREM family have been the focus of intense research in the past years. Individ-
ual mammalian TREM receptors have been found to play a pivotal role in various functions
and diseases including hemostasis and sepsis. The spectrum of different functions is not sur-
prising, since the individual TREM receptors share only limited homology and each show a dis-
tinctive expression pattern [37, 38]. Apart from human and mouse TREM, this family of
receptors has not been studied in great detail. Our analyses of chicken TREM aims to get a bet-
ter understanding in the phylogeny of this receptor family and putatively conserved functions.
It is therefore very important to characterize the expression pattern of individual chicken
TREM receptors and to get insight into their functional potential. In this study, we generated
TREM-B1 specific monoclonal antibodies to characterize cell surface expression patterns and
biochemical properties. Combination of anti-TREM-B1 mab with a variety of different cell sur-
face markers specific for chicken leukocyte subpopulations showed a TREM-B1 expression
Fig 7. TREM-B1 recruits SHP-2 upon phosphorylation. TREM-B1-FLAG transfected 2D8 cells were
treated with pervanadate for the times indicated, lysed and immunoprecipitated using an anti-FLAGmab.
Indicated antibodies were used for detection of the proteins.
doi:10.1371/journal.pone.0151513.g007
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restricted to chicken thrombocytes. These thrombocytes were prepared by cell density gradient
centrifugation from heparinized blood. To exclude unspecific activation of chicken thrombo-
cytes using this separation method, which could potentially induce cell surface expression of
TREM-B1, we also used whole blood preparation which implies a minimum of blood manipu-
lation to exclude any accidental thrombocyte activation. Interestingly, we found no difference
in expression levels comparing the two methods. Furthermore, we also stimulated purified
thrombocytes with LPS to test potential up- or downregulation of TREM-B1 surface expres-
sion, but TREM-B1 expression levels were identical with or without stimulation (data not
shown) indicating a constitutive expression of TREM-B1 on the cell surface of chicken
thrombocytes.
The closest homologue to chicken TREM-B1 in mammals is the TREM-like transcript-1
(TLT-1), which is a member of the TREMmultigene family on human chromosome 6p21 and
mouse chromosome 17C [39–41]. It consists of a single V-set Ig-domain, an uncharged trans-
membrane region and a long cytoplasmic tail with one ITSM and one ITIM [42]. Whereas
chicken thrombocytes display a constitutive TREM-B1 expression, mammalian platelets and
megakaryocytes store TLT-1 in their α granules. TLT-1 surface expression can only be
observed after platelet activation with thrombin, collagen or LPS [43, 44]. In 2009, fibrinogen
Fig 8. TREM-B1 crosslinking reduces CLEC-2 induced thrombocyte degranulation. (A) Co-crosslinking of CLEC-2 and TREM-B1 with the thrombocyte
specific mab 8G8 and 1E9 decreased degranulation (lower panels) compared to co-crosslinking an irrelevant antibody and 8G8 (upper panels). Controls
were incubated without crosslinking and subsequent stained with the respective antibodies. Numbers indicate the percentage of cells in the respective
quadrants. One of five representative experiments is shown. (B) Percentage of TREM-B1 induced inhibition of CLEC-2 mediated thrombocyte degranulation.
Markers represent single values of five different animals. Long bars represent the mean. Short bars represent the standard error of the mean (SEM).
doi:10.1371/journal.pone.0151513.g008
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was identified as the natural ligand for TLT-1 and TLT-1 facilitated platelet aggregation, indi-
cating a function in blood hemostasis [45].
Moreover, soluble TLT-1 was detected in supernatants of activated murine and human
platelets [46]. It was also identified in human serum and plasma and correlated to disseminated
intravascular coagulation scores during sepsis [45]. Subsequent investigations showed that sol-
uble TLT-1 is involved in the inhibition of leukocyte activation during sepsis. As a decoy recep-
tor it competes against TREM-1 for binding to its ligand. This reduces TREM-1 induced pro-
inflammatory cytokine production of neutrophils [47]. Soluble TLT-1 could be thus of thera-
peutic use against sepsis associated inflammation by down regulating the effect of TREM-1 in
the immune response.
Two different sources of soluble TLT-1 are discussed in the literature. There is an alterna-
tively spliced variant of TLT-1, which encodes only for the extracellular domain [45], but solu-
ble TLT-1 is also shed from the surface of activated platelets [46].
Currently, we are investigating the presence of a soluble TREM-B1 in chicken. We have
some evidence that there is an alternatively spliced soluble variant. Moreover, we will also
examine the presence of soluble TREM-B1 shed from the surface of thrombocytes.
In addition to the cell surface expression, the specific anti-TREM-B1 mab 1E9 was used for
immunoprecipitation of TREM-B1 in both stable transfected TREM-B1-FLAG 2D8 cells and
chicken PBMC containing many thrombocytes. Subsequent western blot analysis under non-
reducing and reducing conditions and after deglycosylation showed that TREM-B1 is
expressed as a glycosylated monomer. TREM-B1-FLAG 2D8 cells were further used to analyze
the signaling capabilities of the cytoplasmic region of TREM-B1. There are three tyrosine resi-
dues, which are embedded in either an ITSM (TIYAAI) or two ITIMs (VMYVNI and
VEYATL) [20]. Pervanadate treatment and subsequent western blot analysis showed that these
tyrosine residues are phosphorylated and the tyrosine specific phosphatase SHP-2 is recruited
(Fig 7). Similarly to these results, human TLT-1 has also one ITSM (TTYTSL) and on ITIM
(VTYATV) [39], as does have murine TLT-1 (ITSM: SIYTGS, ITIM: VTYATV) [42]. Initial
experiments showed recruitment of the tyrosine specific phosphatase SHP-1 indicating an
inhibitory potential of the receptor [43]. Another group showed recruitment of SHP-2, which
did not result in inhibition, but in an enhancement of Fc receptor mediated Ca++ release in
RBL cells [48] indicating coactivating potential of TLT-1. Furthermore, Washington et al
showed an interaction of the cytoplasmic region of TLT-1 with cytoskeleton associated ERM
proteins which would contribute to platelet aggregation [45].
Chicken thrombocytes and mammalian platelets differ in various aspects, in particular,
since thrombocytes are nucleated cells. Little is known regarding their immune function but
they react to LPS and express Toll like receptors [49–51]. Additionally, we and other groups
demonstrated the expression of immune relevant cell surface receptor on chicken thrombo-
cytes like CLEC-2, SLAMF4, TREM-A1, CD40L, CD200R-S1 and ggFCR [21, 22, 30, 52–54].
All these findings indicate that chicken thrombocytes might be involved in various types of
immune responses.
We used the ability of CLEC-2 inducing degranulation of thrombocytes [30] for functional
analysis of the potentially inhibitory TREM-B1. By this method we showed that co-crosslinking
of TREM-B1 with CLEC-2 decreased thrombocyte degranulation by about 40–60%. This find-
ing shows that TREM-B1 can act as a true inhibitory receptor.
As a next step to further reveal the TREM-B1 function on thrombocytes, we will focus on
the identification of its natural ligand. For this purpose the TREM-B1 expressing reporter cell
line BWZ.36 will be employed. This reporter assay has already been successfully used by our
group in the identification of various ligands for different chicken Ig-like receptors [13, 23, 52,
55, 56].
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In conclusion, analysis of the chicken TREM-B1 protein expression revealed expression on
thrombocytes, which is similar to its mammalian homologue TLT-1. But chicken TREM-B1 is
constitutively expressed on thrombocytes, while mammalian TLT-1 is only relocated to the cell
surface upon platelet activation. Furthermore, TREM-B1 has been shown to inhibit thrombo-
cyte degranulation. This may indicate a different physiological role of TREM-B1 on chicken
thrombocytes.
Supporting Information
S1 Fig. TREM-B1 is highly expressed by PBMC. RNA from indicated tissues was analyzed for
TREM-B1 expression by real-time RT-PCR using oligonucleotides summarized in Table 2.
Cycle threshold values were normalized on 18S RNA and calibrated on liver using 2-ΔΔCt for-
mula. One representative out of three experiments is shown.
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